Page last updated: 2024-11-11

furapromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

furapromide: structure; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6433308
MeSH IDM0051214

Synonyms (18)

Synonym
n-isopropyl-5-nitro-2-furanacrylamide
n-isopropyl-3-(5-nitro-2-furyl)acrylamide
2-furanacrylamide, n-isopropyl-5-nitro-
n-(1-methylethyl)-3-(5-nitro-2-furanyl)-2-propenamide
n-(isopropyl)-3-(5-nitro-2-furanyl)-2-propenamide
s30066 ,
n-isopropyl-5-nitro-2-furylacrylamide
furapromide
furapromidium
2-propenamide, n-(1-methylethyl)-3-(5-nitro-2-furanyl)-
n-isopropyl-3-(5-nitro-2-furyl)-acrylamide
ccris 1104
(e)-3-(5-nitrofuran-2-yl)-n-propan-2-ylprop-2-enamide
1951-56-0
31365-44-3
n-ipr-3-(5-no2-2-furyl)acrylamide
DTXSID30875965
(e)-n-isopropyl-3-(5-nitrofuran-2-yl)acrylamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]